AZTA 📈 Azenta - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1143401024
AZTA: Cold Storage Solutions, Consumables, Instruments, Gene Sequencing Services
Azenta, Inc. is a life sciences company that specializes in providing comprehensive solutions for biological and chemical compound sample exploration and management. With a global presence spanning the United States, Africa, China, the United Kingdom, Europe, the Asia Pacific, and other international markets, the company caters to a diverse range of clients. Its operations are divided into three primary segments: Sample Management Solutions, Multiomics, and B Medical Systems, each addressing distinct aspects of the life sciences industry.
The Sample Management Solutions segment is focused on delivering innovative products and services that enable efficient sample management, including automated storage systems, cryogenic solutions, and precision instruments. This segment also offers consultation services, providing expert guidance to clients throughout the experimental design and implementation phases. Furthermore, Azenta's sample repository services ensure the secure and controlled storage of valuable biological samples, while its controlled rate thawing devices facilitate the safe handling of temperature-sensitive materials.
In the realm of genomic analysis, the Multiomics segment plays a crucial role, offering a suite of services that encompass gene sequencing, synthesis editing, and related applications. By leveraging cutting-edge technologies, Azenta enables researchers and scientists to gain deeper insights into the complexities of biological systems, driving advancements in fields such as personalized medicine and biotechnology. The company's expertise in multiomics solutions empowers clients to explore new frontiers in life sciences research and development.
The B Medical Systems segment is dedicated to the design, manufacture, and distribution of temperature-controlled storage and transportation solutions. These solutions are critical for maintaining the integrity of biological samples, vaccines, and other temperature-sensitive materials during storage and transit. Azenta's B Medical Systems segment serves a broad range of clients, including governments, health institutions, and non-governmental organizations, helping to ensure the safe and reliable transportation of vital medical supplies.
With a history dating back to 1978, Azenta, Inc. has evolved significantly over the years, adapting to the changing landscape of the life sciences industry. Formerly known as Brooks Automation, Inc., the company underwent a transformation and rebranded as Azenta, Inc. in December 2021. Headquartered in Burlington, Massachusetts, Azenta, Inc. is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol AZTA, with a web presence at https://www.azenta.com. The company's common stock is classified under the GICS Sub Industry: Life Sciences Tools & Services, with an ISIN of US1143401024.
Additional Sources for AZTA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AZTA Stock Overview
Market Cap in USD | 2,285m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Life Sciences Tools & Services |
IPO / Inception | 1995-02-02 |
AZTA Stock Ratings
Growth 5y | -7.99% |
Fundamental | -36.7% |
Dividend | 8.18% |
Rel. Strength Industry | -1301 |
Analysts | 3.43/5 |
Fair Price Momentum | 44.21 USD |
Fair Price DCF | 5.48 USD |
AZTA Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 68.9% |
AZTA Growth Ratios
Growth Correlation 3m | 77.7% |
Growth Correlation 12m | -84.9% |
Growth Correlation 5y | -10.6% |
CAGR 5y | 4.47% |
CAGR/Mean DD 5y | 0.12 |
Sharpe Ratio 12m | -0.52 |
Alpha | -58.31 |
Beta | 1.63 |
Volatility | 38.65% |
Current Volume | 367.5k |
Average Volume 20d | 633.6k |
As of January 10, 2025, the stock is trading at USD 51.81 with a total of 367,546 shares traded.
Over the past week, the price has changed by +3.54%, over one month by +10.61%, over three months by +16.27% and over the past year by -19.94%.
Probably not. Based on ValueRay Fundamental Analyses, Azenta (NASDAQ:AZTA) is currently (January 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -36.71 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AZTA as of January 2025 is 44.21. This means that AZTA is currently overvalued and has a potential downside of -14.67%.
Azenta has received a consensus analysts rating of 3.43. Therefor, it is recommend to hold AZTA.
- Strong Buy: 1
- Buy: 1
- Hold: 5
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, AZTA Azenta will be worth about 50 in January 2026. The stock is currently trading at 51.81. This means that the stock has a potential downside of -3.44%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 56.6 | 9.2% |
Analysts Target Price | 58.5 | 12.9% |
ValueRay Target Price | 50 | -3.4% |